In the European 2000–01 FFCD/SFRO study of gemcitabine alone versus 60 Gy with cisplatin and 5-fluorouracil followed by gemcitabine for patients with unresectable pancreatic cancer, what were the differences in outcomes?
In the European 2000–01 FFCD/SFRO study of gemcitabine alone versus 60 Gy with cisplatin and 5-fluorouracil followed by gemcitabine for patients with unresectable pancreatic cancer, what were the differences in outcomes?